Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
16,423,176
-
Share change
-
+70,867
-
Total reported value
-
$849,847,851
-
Put/Call ratio
-
11%
-
Price per share
-
$51.75
-
Number of holders
-
160
-
Value change
-
+$3,224,170
-
Number of buys
-
87
-
Number of sells
-
53
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2022
As of 31 Dec 2022,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,423,176 shares.
The largest 10 holders included
Royal Bank of Canada, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Robeco Institutional Asset Management B.V., DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, GOLDMAN SACHS GROUP INC, MORGAN STANLEY, and AMERIPRISE FINANCIAL INC.
This page lists
160
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.